Re: Farmas USA
ACAD
Me ha gustado la CC. Si no mienten, y ya hemos visto que son capaces de prácticas éticamente cuestionables (pagando un dineral a médicos y demás), se van a dejar mucha pasta en convencer a gente y parece que ya vuelven a crecer las prescripciones.
La excusa que pone para lo que dijo la otra vez es que no habían empezado a notar aún los efectos del artículo. Si lo que dicen ahora es verdad, lo dejaremos en dudoso. No me gusta nada que mientan directamente porque al final todo se sabe y la credibilidad es lo primero.
--
The invitation that we've seen with patients and caregivers has risen more recently. So, if you recall the CNN articles were in the middle and end of April and our earnings call on May 8, we stated that while it's early and then said be bumpy in the near term as we work through this, we haven't seen a meaningful impact on the business that - at that point in time, would we just change our full year 2018 guidance. At that time, feedback we have from the medical community indicated that our messaging on safety was well understood and that continues to be the case. Since the May 8 earnings call, what has surfaced is concern among patients and caregivers resulting from the CNN article. And as we mentioned, this has resulted in some patients expressing hesitation to start therapy or not following through on therapy to initiate their prescriptions.
As we discussed, we're currently, very, very focused on increasing the level of accurate information in the patient and caregiver community. And did this, as we indicated, we've seen varied instance of stabilization and key demand metrics over the last eight weeks and we believe the initiatives we have underway and those planned will catalyze future growth.